Skip to Content

Current Oncology, Volume 31, Issue 11

2024 November - 68 articles

Cover Story: Antibody drug conjugates (ADCs) are a new class of therapeutic agents designed to target specific antigens on tumor cells, combining the specificity of monoclonal antibodies with the cytotoxicity of chemotherapy agents. Currently, overall, more than 150 ADCs are in clinical trials. ADCs have been available for over a decade, but in gynecological cancers, ADCs have recently come up as a second-line treatment option. Moreover, newer techniques have been incorporated and next-generation ADCs have been created. Some examples include bispecific antibodies, probody drug conjugates (PDCs), immune-stimulating ADCs, degrader–antibody conjugates (DACs), and ADCs with dual chemotherapy. With so much in the pipeline, particularly with the newer techniques, this holds great promise for future. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (68)

  • Article
  • Open Access
2 Citations
1,758 Views
12 Pages

20 November 2024

Both patients and providers experience barriers to discussing complementary medicine during oncology consultations. This study describes the development of two communication tools—a question prompt sheet and a visual slideshow—and aims to...

(This article belongs to the Section Psychosocial Oncology)
  • Systematic Review
  • Open Access
6 Citations
2,871 Views
11 Pages

Electrochemotherapy in the Locoregional Treatment of Metastatic Colorectal Liver Metastases: A Systematic Review

  • Pierluigi Barbieri,
  • Alessandro Posa,
  • Valentina Lancellotta,
  • David C. Madoff and ,
  • Alessandro Maresca,
  • Patrizia Cornacchione,
  • Luca Tagliaferri and
  • Roberto Iezzi
  • + 3 authors+ 0 author

20 November 2024

Background: The global incidence of secondary liver cancer is rising due to multiple risk factors, presenting significant challenges in public health. Similarly, colorectal cancer (CRC) remains a leading cause of cancer-related mortality with the dev...

(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice)
  • Communication
  • Open Access
4 Citations
3,135 Views
13 Pages

Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis

  • Célia Gotorbe,
  • Fabien Segui,
  • William Echavidre,
  • Jérôme Durivault and ,
  • Thays Blanchard,
  • Valérie Vial,
  • Marina Pagnuzzi-Boncompagni,
  • Rémy Villeneuve,
  • Régis Amblard and
  • Christopher Montemagno
  • + 11 authors+ 6 authors

20 November 2024

Medulloblastoma, a malignant pediatric brain tumor, has a poor prognosis upon relapse, highlighting a critical clinical need. Our previous research linked medulloblastoma cell radioresistance to integrin-αvβ3 expression. β3-depleted (...

(This article belongs to the Section Childhood, Adolescent and Young Adult Oncology)
  • Article
  • Open Access
11 Citations
4,538 Views
11 Pages

Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer

  • Sara Frida Cohen,
  • Diane Cruiziat,
  • Jeremy Naimer,
  • Victor Cohen and ,
  • Goulnar Kasymjanova,
  • Alan Spatz and
  • Jason Agulnik
  • + 2 authors+ 0 author

20 November 2024

Background: Immunotherapy with ICIs has revolutionized the treatment for NSCLC. The impact of sex on treatment outcomes remains unclear. The aim of this study was to evaluate sex-related differences in immunotherapy outcomes in a real-world populatio...

(This article belongs to the Special Issue Clinical Management and Outcomes of Lung Cancer Patients)
  • Article
  • Open Access
7 Citations
2,905 Views
16 Pages

Sociocultural and Clinical Determinants of Sexual Dysfunction in Perimenopausal Women with and Without Breast Cancer

  • Osiris G. Delgado-Enciso,
  • Valery Melnikov,
  • Gustavo A. Hernandez-Fuentes,
  • Jessica C. Romero-Michel and ,
  • Daniel A. Montes-Galindo,
  • Veronica M. Guzmán-Sandoval,
  • Josuel Delgado-Enciso,
  • Mario Ramirez-Flores,
  • Iram P. Rodriguez-Sanchez and
  • Ivan Delgado-Enciso
  • + 10 authors+ 5 authors

20 November 2024

Breast cancer survivorship is a recognized risk factor for sexual dysfunction, with various clinical, sociocultural, and psychological factors potentially interacting differently across populations. This study compared sexual dysfunction, anxiety, an...

(This article belongs to the Topic Life of Cancer Survivor)
  • Article
  • Open Access
2 Citations
2,239 Views
11 Pages

19 November 2024

Little is known about the impacts of fatigue after cancer treatment, including whether cancer-related fatigue impacts people’s use of healthcare. This study sought to examine how cancer-related fatigue impacts healthcare use after completing ca...

  • Systematic Review
  • Open Access
3 Citations
4,865 Views
22 Pages

Towards a Risk-Based Follow-Up Surveillance Imaging Schedule for Children and Adolescents with Low-Grade Glioma

  • Kleoniki Roka,
  • Karina J. Kersbergen,
  • Antoinette Y. N. Schouten-van Meeteren,
  • Shivaram Avula and ,
  • Astrid Sehested,
  • Maria Otth and
  • Katrin Scheinemann
  • + 2 authors+ 0 author

18 November 2024

The frequency and duration of imaging surveillance in children and adolescents with pediatric low-grade gliomas (pLGGs) aims for the early detection of recurrence or progression. Although surveillance of pLGGs is performed routinely, it is not yet st...

(This article belongs to the Section Childhood, Adolescent and Young Adult Oncology)
  • Case Report
  • Open Access
2 Citations
3,178 Views
11 Pages

Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

  • Luis Posado-Domínguez,
  • María Escribano-Iglesias,
  • Lorena Bellido-Hernández,
  • Johana Gabriela León-Gil and ,
  • María Asunción Gómez-Muñoz,
  • Felipe Gómez-Caminero López,
  • María Martín-Galache,
  • Sandra M. Inés-Revuelta and
  • Emilio Fonseca-Sánchez
  • + 4 authors+ 0 author

18 November 2024

Summary: Anti PD1/PD-L1 agents, including pembrolizumab, have revolutionized the oncological treatment of different types of cancer, including non-small cell lung cancer. The most frequent complications associated with this type of treatment are mild...

(This article belongs to the Section Thoracic Oncology)
  • Case Report
  • Open Access
4 Citations
2,667 Views
11 Pages

Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression

  • Miguel A. Diaz,
  • Felisa Vázquez-Gómez,
  • Irene Garrido,
  • Francisco Arias and ,
  • Julia Suarez,
  • Ismael Buño and
  • Álvaro Lassaletta
  • + 2 authors+ 0 author

18 November 2024

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, with a median overall survival (OS) of 15–18 months despite standard treatments. Approximately 8% of GBM cases exhibit genomic alterations in fibroblast growth facto...

  • Commentary
  • Open Access
1 Citations
2,031 Views
7 Pages

18 November 2024

This brief commentary describes the reflections on a fundamental question by the Public Interest Group on Cancer Research, a successful academic-community partnership focused on cancer research, education, public engagement, and advocacy in Canada&rs...

(This article belongs to the Special Issue The 30th Anniversary of Current Oncology: Perspectives in Clinical Oncology Practice)
  • Article
  • Open Access
3 Citations
2,481 Views
14 Pages

Bouncing Beyond Adversity in Oncology: An Exploratory Study of the Association Between Professional Team Resilience at Work and Work-Related Sense of Coherence

  • Dominique Tremblay,
  • Djamal Berbiche,
  • Mathieu Roy,
  • Catherine Prady and ,
  • Marie-José Durand,
  • Marjolaine Landry and
  • Sylvie Lessard
  • + 2 authors+ 0 author

17 November 2024

Team resilience at work (TR@W) is an important resource for bouncing beyond adverse situations. Adopting a health-promoting salutogenic approach, this cross-sectional study explores whether oncology team resilience, which is significantly associated...

(This article belongs to the Special Issue Feature Reviews in Section "Oncology Nursing")
  • Review
  • Open Access
7 Citations
4,648 Views
12 Pages

17 November 2024

Immunotherapy, particularly immune checkpoint inhibitors like PD-1, PD-L1, and CTLA-4, has revolutionized cancer treatment. However, the role of the innate immune system, especially pattern recognition receptors, in cancer development and immunity is...

  • Article
  • Open Access
2,727 Views
17 Pages

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant

  • Richard LeBlanc,
  • Stéphanie Thiant,
  • Rafik Terra,
  • Imran Ahmad and ,
  • Jean-Sébastien Claveau,
  • Nadia Bambace,
  • Léa Bernard,
  • Sandra Cohen,
  • Jean-Sébastien Delisle and
  • Jean Roy
  • + 9 authors+ 4 authors

16 November 2024

Background: To date, the only potential curative treatment for multiple myeloma (MM) remains allogeneic (allo) hematopoietic cell transplant (HCT), although, most patients will eventually relapse. In relapsed patients, donor lymphocyte infusions (DLI...

(This article belongs to the Section Cell Therapy)
  • Article
  • Open Access
5 Citations
3,923 Views
14 Pages

Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States

  • Anivarya Kumar,
  • Jennifer R. Owen,
  • Nicholette T. Sloat,
  • Elizabeth Maynard and ,
  • Vanessa M. Hill,
  • Christopher B. Hubbard,
  • Matthew S. McKinney,
  • Linda M. Sutton,
  • Shannon J. McCall and
  • Ryne C. Ramaker
  • + 9 authors+ 4 authors

16 November 2024

Targeting tumor-specific molecular alterations has shown significant clinical benefit. Molecular tumor boards (MTBs) connect cancer patients with personalized treatments and clinical trials. However, rural cancer centers often have limited access to...

  • Guidelines
  • Open Access
5 Citations
5,692 Views
18 Pages

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer

  • Jeffrey Q. Cao,
  • Brae Surgeoner,
  • Mita Manna,
  • Jean-François Boileau and ,
  • Karen A. Gelmon,
  • Muriel Brackstone,
  • Christine Brezden-Masley,
  • Katarzyna J. Jerzak,
  • Ipshita Prakash and
  • Jan-Willem Henning
  • + 12 authors+ 7 authors

15 November 2024

The accurate staging of breast cancer is fundamental for guiding treatment decisions and predicting patient outcomes. However, there can be considerable variation in routine clinical practice based on individual interpretation of guidelines and depen...

(This article belongs to the Special Issue The 30th Anniversary of Current Oncology: Perspectives in Clinical Oncology Practice)
  • Systematic Review
  • Open Access
6 Citations
3,880 Views
22 Pages

Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis

  • Junaid Anwar,
  • Hafiz Muhammad Arslan,
  • Zouina Sarfraz,
  • Juwairiya Shuroog and ,
  • Ahmed Abdelhakeem,
  • Ali Saeed and
  • Anwaar Saeed
  • + 2 authors+ 0 author

15 November 2024

Background: Hepatocellular carcinoma (HCC) is a prevalent liver cancer with poor prognosis, often linked to hepatitis B (HBV) and C (HCV) infections. This meta-analysis evaluates the efficacy of immunotherapy in HCC, particularly in cases arising fro...

(This article belongs to the Section Gastrointestinal Oncology)
  • Review
  • Open Access
9 Citations
3,275 Views
14 Pages

Soft Tissue Reconstruction and Integration to Implant After Bone-Tumor Resection: A Current Concept Review

  • Elisa Pesare,
  • Raffaele Vitiello,
  • Tommaso Greco,
  • Giuseppe Solarino and ,
  • Giulio Maccauro and
  • Antonio Ziranu
  • + 1 author+ 0 author

15 November 2024

Introduction: With the advancements in chemotherapy for malignant bone tumors, the number of patients eligible for limb salvage surgery has increased. Surgeons face a subsequent challenge in limb-sparing resection due to the need for reconstructing s...

(This article belongs to the Section Bone and Soft Tissue Oncology)
  • Article
  • Open Access
8 Citations
3,374 Views
10 Pages

Clinically Significant Prostate Cancer Prediction Using Multimodal Deep Learning with Prostate-Specific Antigen Restriction

  • Hayato Takeda,
  • Jun Akatsuka,
  • Tomonari Kiriyama,
  • Yuka Toyama and ,
  • Yasushi Numata,
  • Hiromu Morikawa,
  • Kotaro Tsutsumi,
  • Mami Takadate,
  • Hiroya Hasegawa and
  • Yoichiro Yamamoto
  • + 14 authors+ 9 authors

15 November 2024

Prostate cancer (PCa) is a clinically heterogeneous disease. Predicting clinically significant PCa with low–intermediate prostate-specific antigen (PSA), which often includes aggressive cancers, is imperative. This study evaluated the predictiv...

(This article belongs to the Section Genitourinary Oncology)
  • Correction
  • Open Access
1 Citations
1,500 Views
3 Pages

Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097–6110

  • Alberto Alvarado-Miranda,
  • Fernando Ulises Lara-Medina,
  • Wendy R. Muñoz-Montaño,
  • Juan W. Zinser-Sierra and ,
  • Paula Anel Cabrera Galeana,
  • Cynthia Villarreal Garza,
  • Daniel Sanchez Benitez,
  • Jesús Alberto Limón Rodríguez,
  • Claudia Haydee Arce Salinas and
  • Oscar Arrieta
  • + 6 authors+ 1 author

15 November 2024

In the original publication [...]

  • Article
  • Open Access
2,254 Views
12 Pages

15 November 2024

Children with lived cancer experience encounter adversity, therefore experiences promoting psychosocial health are necessary. This pilot study determined the impact of recreational oncology camps (ROC) on resilience, hope, social support, and mental...

(This article belongs to the Section Childhood, Adolescent and Young Adult Oncology)
  • Article
  • Open Access
1 Citations
2,477 Views
11 Pages

Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors

  • Takuya Azechi,
  • Yutaka Fukaya,
  • Chika Nitani,
  • Junichi Hara and ,
  • Hiroshi Kawamoto,
  • Tomoaki Taguchi,
  • Kenichi Yoshimura,
  • Akihiro Sato,
  • Naoko Hattori and
  • Toshimi Kimura
  • + 6 authors+ 1 author

14 November 2024

Tamibarotene is a synthetic retinoid that inhibits tumor cell proliferation and promotes differentiation. We previously reported on the safety and tolerability of tamibarotene in patients with recurrent or refractory solid tumors. Therefore, in this...

(This article belongs to the Section Childhood, Adolescent and Young Adult Oncology)
  • Article
  • Open Access
4 Citations
3,220 Views
11 Pages

Facilitation of Enrollment onto Cancer Clinical Trials Using a Novel Navigator-Assisted Program: A Cross-Sectional Study

  • Mahmoud Hossami,
  • Rhonda Abdel-Nabi,
  • Farwa Zaib,
  • Kayla Touma and ,
  • Renee Nassar,
  • Sanghyuk Claire Rim,
  • Milica Paunic,
  • Olla Hilal,
  • Pratham Gupta and
  • Caroline Hamm
  • + 16 authors+ 11 authors

14 November 2024

Introduction: Clinical trials are essential to the advancement of clinical therapies that improve the outcomes of people with cancer. However, enrollment in clinical trials remains a challenge. The Clinical Trial Navigator [CTN] Program was designed...

  • Systematic Review
  • Open Access
14 Citations
4,202 Views
15 Pages

13 November 2024

Immune checkpoint inhibitors (ICIs) significantly improve survival, while immune-mediated hepatotoxicity (IMH) has been reported. To evaluate the incidence and potential risk factors of IMH among cancer patients treated by ICIs, PubMed/Medline, Web o...

  • Case Report
  • Open Access
2 Citations
2,522 Views
12 Pages

13 November 2024

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from plasmacytoid dendritic cells. It commonly presents as cutaneous lesions. To date, no standard treatment protocol for BPDCN exists. Tra...

(This article belongs to the Topic Cancer Biology and Radiation Therapy: 2nd Edition)
  • Article
  • Open Access
2 Citations
2,435 Views
10 Pages

Urinary Diversion Can Improve the Chance of Implementing New Therapeutic Lines in Patients with Malignant Ureteral Obstruction: A Multicenter Study

  • Marcelo Cartapatti,
  • Roberto Dias Machado,
  • José Carlos Mesquita,
  • Raphael Freua and ,
  • Diego Cáceres and
  • Rodolfo Borges dos Reis
  • + 1 author+ 0 author

13 November 2024

Purpose: Malignant ureteral obstruction is generally associated with a poor disease prognosis; therefore, managing these cases is challenging. We describe our experience in treating malignant ureteral obstruction with urinary diversion and the impact...

(This article belongs to the Section Surgical Oncology)
  • Review
  • Open Access
15 Citations
6,153 Views
19 Pages

13 November 2024

Antibody–drug conjugates (ADCs) are a new class of therapeutic agents designed to target specific antigens on tumor cells, combining the specificity of monoclonal antibodies with the cytotoxicity of chemotherapy agents. ADCs have been available...

(This article belongs to the Topic Recent Advances in Anticancer Strategies)
  • Article
  • Open Access
2 Citations
1,845 Views
14 Pages

The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma

  • Isabelle J. H. Jang,
  • Hanis B. Abdul Kadir,
  • Kok Hing Lim,
  • Wen Chao Daniel Chew and ,
  • Jacqueline S. G. Hwang and
  • Chwee Ming Lim
  • + 1 author+ 0 author

12 November 2024

Purpose: The neutrophil-to-lymphocyte ratio is a simple biomarker that reflects the balance between the systemic inflammatory and immunity status. Here we investigate the prognostic role of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in an Asi...

(This article belongs to the Section Head and Neck Oncology)
  • Article
  • Open Access
10 Citations
2,604 Views
13 Pages

Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study

  • Emily Rinderknecht,
  • Dominik von Winning,
  • Anton Kravchuk,
  • Christof Schäfer and ,
  • Marco J. Schnabel,
  • Stephan Siepmann,
  • Roman Mayr,
  • Jochen Grassinger,
  • Christopher Goßler and
  • Matthias May
  • + 14 authors+ 9 authors

11 November 2024

The integration of artificial intelligence, particularly Large Language Models (LLMs), has the potential to significantly enhance therapeutic decision-making in clinical oncology. Initial studies across various disciplines have demonstrated that LLM-...

(This article belongs to the Special Issue Shaping the Future of Oncology: The Role of Generative AI in Clinical and Research Environments)
  • Article
  • Open Access
2,625 Views
10 Pages

11 November 2024

Liver transplants (LTs) are prioritized by mortality risk, which is estimated by MELD scores. Since hepatocellular carcinoma (HCC) patients present with lower MELD scores, they are allocated MELD exception points. Concerns persist that HCC recipients...

  • Article
  • Open Access
1 Citations
1,872 Views
11 Pages

Evaluating the Efficacy of Immunotherapy in Fragile Hospitalized Patients

  • Charles Vincent Rajadurai,
  • Guillaume Gagnon,
  • Catherine Allard,
  • Mandy Malick and
  • Michel Pavic

10 November 2024

Background: Immunotherapy is the cornerstone of treatment for many cancers. The effectiveness of immunotherapy in hospitalized patients is unknown due to the exclusion of this fragile population from clinical trials. This study evaluates the efficacy...

  • Systematic Review
  • Open Access
15 Citations
3,340 Views
17 Pages

Disability and Participation in Colorectal Cancer Screening: A Systematic Review and Meta-Analysis

  • Giovanni Emanuele Ricciardi,
  • Rita Cuciniello,
  • Emanuele De Ponti,
  • Carlo Lunetti and ,
  • Flavia Pennisi,
  • Carlo Signorelli and
  • Cristina Renzi
  • + 2 authors+ 0 author

10 November 2024

Background: The aim of this study is to assess the impact of disability on participation in CRC screening and to determine the overall effect size. Methods: We conducted a systematic review and meta-analysis to compare CRC screening participation in...

  • Article
  • Open Access
4 Citations
5,214 Views
9 Pages

Brain Metastasis in Pediatric Patients with Osteosarcoma

  • Jacob Murphy,
  • R. Taylor Sundby,
  • Erin E. Resch,
  • Ruyan Rahnama and ,
  • Kathryn M. Lemberg,
  • Alexandre Maalouf,
  • Aditya Suru,
  • Jason Fixler,
  • Brian H. Ladle and
  • Christine A. Pratilas
  • + 14 authors+ 9 authors

9 November 2024

Background: Brain metastases in pediatric osteosarcoma are infrequent but associated with a dire prognosis. Methods: This retrospective study examined six pediatric patients at Johns Hopkins Hospital who developed brain metastases from osteosarcoma b...

  • Article
  • Open Access
12 Citations
3,048 Views
14 Pages

Sleep Quality in Head and Neck Cancer

  • Giancarlo Pecorari,
  • Simone Moglio,
  • Dario Gamba,
  • Marco Briguglio and ,
  • Ester Cravero,
  • Eugenio Sportoletti Baduel and
  • Giuseppe Riva
  • + 2 authors+ 0 author

9 November 2024

Background: Patients with head and neck cancer often experience impaired sleep. Moreover, the treatment may negatively affect sleep quality. The aim of this observational study was to evaluate the sleep quality after treatment for head and neck cance...

  • Review
  • Open Access
5 Citations
4,257 Views
21 Pages

Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum

  • Parneet K. Cheema,
  • Paul F. Wheatley-Price,
  • Matthew J. Cecchini,
  • Peter M. Ellis and ,
  • Alexander V. Louie,
  • Sara Moore,
  • Brandon S. Sheffield,
  • Jonathan D. Spicer,
  • Patrick James Villeneuve and
  • Natasha B. Leighl
  • + 5 authors+ 0 author

8 November 2024

Therapeutic strategies for early-stage non-small cell lung cancer (NSCLC) are advancing, with immune checkpoint inhibitors (ICIs) and targeted therapies making their way into neoadjuvant and adjuvant settings. With recent advances, there was a need f...

(This article belongs to the Special Issue The 30th Anniversary of Current Oncology: Perspectives in Clinical Oncology Practice)
  • Article
  • Open Access
2 Citations
4,229 Views
23 Pages

Advancing Research Alongside Patient Partners: Next-Generation Best Practices for Effective Collaboration in Health Research

  • Ally C. Farrell,
  • Jessica A. Lawson,
  • Ovarian Cancer Canada’s Patient Partners in Research Team,
  • Alison Ross and
  • Alicia A. Tone

7 November 2024

Ovarian Cancer Canada’s Patient Partners in Research (PPiR) is a national volunteer-based program that trains and connects individuals with lived ovarian cancer (OC) experience to diverse research opportunities, to maximize the clinical relevan...

(This article belongs to the Special Issue Ovarian Cancer in the Age of Precision Medicine)
  • Article
  • Open Access
4 Citations
5,051 Views
18 Pages

Revalidation of Proactive Gastrostomy Tube Placement Guidelines for Head and Neck Cancer Patients Receiving Helical Intensity-Modulated Radiotherapy

  • Teresa E. Brown,
  • Angela Byrnes,
  • Aaron C. Chan,
  • Kathleen Dwyer and ,
  • Anna Edwards,
  • Claire L. Blake,
  • Merrilyn D. Banks,
  • Brett G. M. Hughes,
  • Charles Y. Lin and
  • Judith D. Bauer
  • + 7 authors+ 2 authors

6 November 2024

The Royal Brisbane and Women’s Hospital (RBWH) Swallowing and Nutrition Management Guidelines for Patients with Head and Neck Cancer were developed to enable evidence-based decision-making by the Head and Neck Multidisciplinary Team (H&N MD...

  • Review
  • Open Access
8 Citations
4,980 Views
29 Pages

The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers

  • Ryan Michael Antar,
  • Christopher Fawaz,
  • Diego Gonzalez,
  • Vincent Eric Xu and ,
  • Arthur Pierre Drouaud,
  • Jason Krastein,
  • Faozia Pio,
  • Andeulazia Murdock,
  • Kirolos Youssef and
  • Michael J. Whalen
  • + 6 authors+ 1 author

6 November 2024

The genetic landscape of urologic cancers has evolved with the identification of actionable mutations that impact diagnosis, prognosis, and therapeutic strategies. This narrative review consolidates existing literature on genetic mutations across key...

(This article belongs to the Section Genitourinary Oncology)
  • Review
  • Open Access
8 Citations
9,543 Views
11 Pages

Current Trends in the Surgical Management of Yolk Sac Tumors

  • Małgorzata Edyta Wojtyś,
  • Konstantinos Kostopanagiotou,
  • Dawid Kordykiewicz,
  • Patryk Skórka and ,
  • Alexandros Polykarpos Gkioulekas,
  • Julia Augusta Guimarães Dourado,
  • Janusz Wójcik and
  • Periklis Tomos
  • + 3 authors+ 0 author

6 November 2024

Mediastinal yolk sac tumors (YST) constitute a highly malignant subtype of primary non-seminomatous germ cell tumors, which are often locally advanced and unresectable at diagnosis. Due to their rarity and aggressiveness, there is not yet a standard...

(This article belongs to the Section Thoracic Oncology)
  • Case Report
  • Open Access
1 Citations
3,267 Views
7 Pages

Anti-Cancer Drug-Induced Lyell’s Syndrome: A Series of Two Patients

  • Julie Coussirou,
  • Magali Ravoire,
  • Alma Stancu and
  • Léa Vazquez

4 November 2024

Lyell’s syndrome or Toxic Epidermal Necrolysis (TEN) is a rare and life-threatening dermatological disease. Most commonly, this syndrome is drug-induced, and is a result of an immune-allergic reaction to medications. Anti-cancer drugs were not...

  • Systematic Review
  • Open Access
2 Citations
3,892 Views
12 Pages

The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis

  • Natale Quartuccio,
  • Vincenzo Militano,
  • Marco Pappalardo,
  • Luca Filippi and ,
  • Oreste Bagni,
  • Antonino Maria Moreci and
  • Salvatore Ialuna
  • + 2 authors+ 0 author

3 November 2024

Aim: To meta-analyze the utility of transarterial radioembolization (TARE) in patients with liver metastatic breast cancer (BC), based on the objective response rate (ORR) and disease control rate (DCR). Methods: A literature search was performed ret...

(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice)
  • Review
  • Open Access
18 Citations
18,968 Views
12 Pages

Malignant Pleural Effusion: Diagnosis and Treatment—Up-to-Date Perspective

  • Riccardo Orlandi,
  • Andrea Cara,
  • Enrico Mario Cassina,
  • Sara Degiovanni and ,
  • Lidia Libretti,
  • Emanuele Pirondini,
  • Federico Raveglia,
  • Antonio Tuoro,
  • Sara Vaquer and
  • Francesco Petrella
  • + 6 authors+ 1 author

2 November 2024

Malignant pleural effusion is the presence of malignant cells within the pleural fluid, representing the second most common cause of pleural exudate. Although diagnostic methods and management techniques for malignant pleural effusion have dramatical...

  • Article
  • Open Access
10 Citations
4,078 Views
14 Pages

Prophylactic Swallowing Exercises in Patients with Laryngeal Cancer Who Underwent Total Laryngectomy—A Randomized Trial

  • Elena Teodora Schipor-Diaconu,
  • Raluca Grigore,
  • Paula Luiza Bejenaru,
  • Catrinel Beatrice Simion-Antonie and ,
  • Bianca Petra Taher,
  • Simona Andreea Rujan,
  • Anca Ionela Cirstea,
  • Raluca Andreea Iftimie and
  • Ruxandra Ioana Stancalie-Nedelcu
  • + 4 authors+ 0 author

2 November 2024

Objectives: This study aims to determine the efficacy of prophylactic swallowing exercises on swallowing function in patients undergoing total laryngectomy for laryngeal cancer. Methods: The design was a randomized controlled trial set in one tertiar...

(This article belongs to the Section Surgical Oncology)
  • Article
  • Open Access
2 Citations
3,208 Views
13 Pages

Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer

  • Riccardo Ray Colciago,
  • Chiara Chissotti,
  • Federica Ferrario,
  • Maria Belmonte and ,
  • Giorgio Purrello,
  • Valeria Faccenda,
  • Denis Panizza,
  • Stefania Canova,
  • Gaia Passarella and
  • Stefano Arcangeli
  • + 6 authors+ 1 author

2 November 2024

We aimed to evaluate whether progression-directed radiation therapy (PDRT) can prolong the initiation of a subsequent systemic therapy regimen in a cohort of patients with oligoprogressive NSCLC. A retrospective analysis was conducted on NSCLC patien...

(This article belongs to the Special Issue Hype or Hope—Combination Therapies for Lung Cancer)
  • Article
  • Open Access
5 Citations
2,219 Views
11 Pages

Predictive Value of GINI and ALBI Grades in Esophageal Cancer Receiving Chemoradiotherapy

  • Timur Koca,
  • Busra Hasdemir,
  • Rahmi Atıl Aksoy and
  • Aylin Fidan Korcum

2 November 2024

Objectives: The principal objective of this study was to assess the predictive efficacy of the global immune–nutrition–inflammation index (GINI) and the albumin–bilirubin (ALBI) score among patients receiving chemoradiotherapy for e...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
9 Citations
6,395 Views
15 Pages

Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI

  • Laura J. Jensen,
  • Damon Kim,
  • Thomas Elgeti,
  • Ingo G. Steffen and ,
  • Lars-Arne Schaafs,
  • Matthias Haas,
  • Lukas J. Kurz,
  • Bernd Hamm and
  • Sebastian N. Nagel
  • + 4 authors+ 0 author

1 November 2024

Prostate Imaging Reporting and Data System version 2.1 (PI-RADS) category 3 lesions are a challenge in the clinical workflow. A better detection of the infrequently occurring clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions is an i...

(This article belongs to the Special Issue Shaping the Future of Oncology: The Role of Generative AI in Clinical and Research Environments)
  • Article
  • Open Access
4 Citations
2,748 Views
11 Pages

Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

  • Sercan Ön,
  • Barış Köksal,
  • Zafer Arık,
  • Burcu Caner and ,
  • Duygu Ercan Uzundal,
  • Ozan Yazıcı,
  • Burcu Arslan Benli,
  • Eda Eylemer Mocan,
  • Can Cangür and
  • Ulus Ali Şanlı
  • + 11 authors+ 6 authors

1 November 2024

(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines. This study was designed to evaluate the real-life effectiveness a...

  • Article
  • Open Access
3 Citations
3,070 Views
12 Pages

Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

  • Alessio Bruni,
  • Vieri Scotti,
  • Maria Alessia Zerella,
  • Federica Bertolini and ,
  • Jessica Imbrescia,
  • Emanuela Olmetto,
  • Chiara Bennati,
  • Francesco Cuccia,
  • Marianna Miele and
  • Paolo Borghetti
  • + 14 authors+ 9 authors

1 November 2024

Background: Extensive-stage small-cell lung cancer (ES-SCLC) treatment has recently been revolutionized by the advent of immune checkpoint inhibitors. This survey was conducted to evaluate the current pattern of care among Italian clinicians, in part...

(This article belongs to the Special Issue Hype or Hope—Combination Therapies for Lung Cancer)
  • Article
  • Open Access
1 Citations
4,062 Views
13 Pages

Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma

  • Angélica Richart Csipak,
  • Leonardo G. da Fonseca,
  • Rossana Verónica Mendoza López and
  • Maria Del Pilar Estevez-Diz

1 November 2024

Background: Hepatocellular carcinoma (HCC) accounts for approximately 90% of liver cancer cases. Sorafenib, the first drug to demonstrate survival benefits for advanced HCC, was validated through the SHARP randomized clinical trial (RCT). While RCTs...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
2 Citations
2,163 Views
11 Pages

Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean BRCA1/2 Mutation Carriers

  • Dabin Kim,
  • Jai Min Ryu,
  • Sang-Ah Han,
  • Zisun Kim and
  • Sung-Won Kim

1 November 2024

The lifetime risk of breast and ovarian cancer increases substantially for individuals with mutations in BRCA1/2. The evidence indicates that BRCA1/2 mutation carriers benefit from early cancer detection and prevention strategies. However, data on th...

  • Article
  • Open Access
2 Citations
2,594 Views
18 Pages

1 November 2024

Cervical cancer is largely preventable through screening and treatment of cervical lesions. In the province of Ontario, South Asian women have some of the lowest rates of screening. The roles of service providers—those in healthcare and communi...

(This article belongs to the Special Issue Action and Impact: Prevention and Screening Strategies Contributing to the Elimination of Cervical Cancer)

of 2

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729